An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Jon Krakauer: “Missoula”

Thursday, Apr 23 2015A conversation with best-selling writer Jon Krakauer on his latest book of non-fiction. The author of “Into the Wild” and “Into Thin Air” chronicles the lives of several women allegedly raped on campus at the University of Montana.

Jane Smiley: “Early Warning”

Wednesday, Apr 22 2015In the novel "Some Luck," Jane Smiley introduced readers to the Langdons, a Depression-era Iowa farm family. Now, the Pulitzer Prize-winner follows their story through the Cold War, Vietnam and the turbulent 1960s and '70s. Smiley joins us to talk about her new novel, "Early Warning."